Phenomic AI Tackles Drug Discovery with AI-driven High-throughput Phenotypic Screens Using Antibody-based Assays
Easily Find and Compare Antibodies You Need With Our Latest Catalog and Search Updates
Omer Donmez on Antibodies for Elucidating the Roles of Transcription Factors in Lupus Etiology
Naheed Kurji, CEO of Cyclica, on Building an AI Platform to Design, Screen, and Personalize Drugs
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Stephanie Guerra on Antibodies for Characterizing Novel Combination Therapies for KRAS-mutant Lung Adenocarcinoma
Regina Barzilay on AI for Small Molecule Discovery and Synthesis
Tim Guilliams and David Brown, Healx, on AI for Rare Diseases
John Cassidy, CEO of Cambridge Cancer Genomics, on AI-Powered Disease Prediction for Oncology
Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research
Immunohistochemistry (IHC): Principles & Factors to Consider For Quality Results

Never miss a blog post